Donald M. Gleason

Medicine · Health Sciences

25h-index5.2kcitations90works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Urinary Bladder and Prostate Research(28), Pelvic floor disorders treatments(24), Prostate Cancer Treatment and Research(21), Urological Disorders and Treatments(17), Prostate Cancer Diagnosis and Treatment(15)

Publications90 total

PD08-05 CROSS VALIDATION OF AN UPDATED PREDICTIVE ANALYTIC MODEL WHICH PREDICTS SUCCESS AND COMPLICATIONS OF SHOCKWAVE LITHOTRIPSY IN THE TREATMENT OF URINARY STONES
The Journal of Urology·2018Open Access
MP62-19 CROSS VALIDATION OF A PREDICTIVE ANALYTIC MODEL WHICH PREDICTS SUCCESS AND COMPLICATIONS OF SHOCKWAVE LITHOTRIPSY
The Journal of Urology·2017· 1 citedOpen Access
DEVELOPMENT AND FABRICATION OF A LIGHT CURING BASED RAPID PROTOTYPING SYSTEM
2011
Safety and Side Effects of Immediate Instillation of Apaziquone Following Transurethral Resection in Patients With Nonmuscle Invasive Bladder Cancer
The Journal of Urology·2008· 22 cited
Survivors' Weekend Supporting Those Left Behind
PsycEXTRA Dataset·2008
Continuing Benefit of Zoledronic Acid in Preventing Skeletal Complications in Patients with Bone Metastases
Clinical Cancer Reviews·2007· 4 citedOpen Access
Continuing Benefit of Zoledronic Acid in Preventing Skeletal Complications in Patients with Bone Metastases
Clinical Genitourinary Cancer·2007· 51 cited
The Bicalutamide 150 Mg Early Prostate Cancer Program: Findings of the North American Trial at 7.7-Year Median Followup
The Journal of Urology·2006· 46 cited
1588: The Bicalutamide Early Prostate Cancer Program: Findings of the North American Trial at 7.7 Years' Median Follow-Up
The Journal of Urology·2006
ZOLEDRONIC ACID REDUCES SKELETAL MORBIDITY REGARDLESS OF PREVIOUS SKELETAL EVENTS IN MEN WITH PROSTATE CANCER AND BONE METASTASES
European Urology Supplements·2006· 7 cited
Effect of zoledronic acid on bone pain and skeletal morbidity in patients with advanced prostate cancer; analysis by baseline pain
Journal of Clinical Oncology·2005· 10 cited
674: The Bicalutamide Early Prostate Cancer Program: Findings of the North American Trial at Median 5.7 Years' Follow-Up
The Journal of Urology·2005· 1 citedOpen Access
567Zoledronic acid provides long-term reduction of bone pain in patients with bone metastases secondary to prostate cancer
European Urology Supplements·2005
572Long-term reduction of bone pain and skeletal morbidity with zoledronic acid in patients with prostate cancer and bone metastases
European Urology Supplements·2005· 9 cited
Continuing benefit of zoledronic acid for the prevention of skeletal complications in men with advanced prostate cancer
Journal of Clinical Oncology·2004· 10 cited
Continuing benefit of zoledronic acid for the prevention of skeletal complications in men with advanced prostate cancer
Journal of Clinical Oncology·2004· 8 cited
Clinical benefit of zoledronic acid for the prevention of skeletal complications in patients with prostate cancer based on history of skeletal complications
Journal of Clinical Oncology·2004· 5 cited
Is the efficacy of hormonal therapy affected by lymph node status? data from the bicalutamide (Casodex) Early Prostate Cancer program
Urology·2004· 18 cited
615 Long-term efficacy and safety of zoledronic acid in men with advanced prostate cancer and bone metastases
European Urology Supplements·2004· 13 cited
Randomized Controlled Trial of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Nonmetastatic Prostate Cancer
The Journal of Urology·2003· 644 cited
page 1 of 5Next →

Frequent Co-authors

Manfred R. Bottaccini(18), John K. Lattimer(10), Fred Saad(7), Ira Klimberg(5), Robin Murray(4), Louis Lacombe(4), Joseph L. Chin(4), David G. McLeod(4), Robert J. Reilly(4), John Byrne(4), Ming Zheng(4), P. Venner(3), James A. Eastham(3), Norman R. Zinner(3), William A. See(3), Gerald W. Chodak(3), James E. Montie(3), J. Vinholes(3), J. A. Goas(2), Simon Tchekmedyian(2)